Gerresheimer stock weighs Q3 growth against margin pressure

Published on 11/10/2026 at 12:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock posted 8% third-quarter revenue growth, but profitability remained under pressure. Management expects a stronger fourth quarter.

Key points for investors

Adjusted EBITDA reached EUR 103 million in the third quarter, while the margin narrowed to 17.1 percent.
First-nine-month adjusted EBITDA fell to EUR 272 million from EUR 331 million a year earlier.
Management expects a stronger fourth quarter and plans to publish final Q3 figures in December 2026.

Gerresheimer, DE000A0LD6E6, Illustration mit AI erstellt.

Gerresheimer released preliminary third-quarter and nine-month results on October 30, 2026. According to the company's Q3 announcement, revenue including business units currently in the sales process rose 8 percent year over year to EUR 605 million. The adjusted comparison base for the third quarter was EUR 560 million.

Adjusted EBITDA reached EUR 103 million, compared with EUR 106 million in the adjusted prior-year quarter. The adjusted EBITDA margin narrowed to 17.1 percent from 19.0 percent. Gerresheimer attributed the pressure on earnings in part to inventory reductions and weaker performance in Tubular Glass Europe and Moulded Glass.

Growth meets margin pressure

Revenue for the first nine months was approximately EUR 1.7 billion, broadly in line with the adjusted prior-year period. Adjusted EBITDA, however, fell to EUR 272 million from EUR 331 million. The nine-month adjusted EBITDA margin declined to 15.9 percent from 19.4 percent.

The quarterly performance was mixed across the portfolio. Gerresheimer said the Containment and Delivery Systems business benefited from demand for drug-delivery products, while Tubular Glass Europe and Moulded Glass weighed on profitability. The figures include business units that were still in the sales process at the time of the release.

Management expects a stronger fourth quarter with further earnings improvement and said the full-year outlook remains in line with existing guidance. CFO Wolf Lehmann said the revenue increase, stable quarterly adjusted EBITDA and the successful completion of the Centor sale in October marked progress in the company's transformation.

Portfolio changes remain important

The Centor transaction completed on October 1 and improved Gerresheimer's financial position, according to the company. For investors, the key issue is whether stronger fourth-quarter demand and the ongoing transformation can offset the margin weakness visible in the first nine months.

Gerresheimer stock traded at 31.30 euros on Lang & Schwarz at 12:21 CET on Tuesday, November 10, 2026.